Trial · NCT04291001
Ovarian Function With ENG Implant and UPA Use
NCT04291001, Early phase 1, Completed, University of Utah; results first posted 2024-07-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ovarian Function With ENG Implant and UPA Use. Trials, record NCT04291001. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04291001
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ovarian Function With ENG Implant and UPA Use
- NCT number
- NCT04291001
- Status
- Completed
- Phases
- Early phase 1
- Enrollment
- 40 participants, actual
- Lead sponsor
- University of Utah
- Conditions
- Contraception
- Interventions
- ENG implant, oral ulipristal acetate
- First posted
- 2020-03-02
- Last updated
- 2024-07-12
- Results first posted
- 2024-07-12
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Ovulation With Implant-alone | 5 days | Ovulation will be monitored by ultrasound and serum LH and progesterone levels |
| Primary | Number of Participants With Ovulation With Implant and Same Day UPA | 5 days | Ovulation will be monitored by ultrasound and serum LH and progesterone levels |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Ovulation With Implant-alone | 5 days | Outcome Measure was pre-specified to assess ENG Implant Alone | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants With Ovulation With Implant and Same Day UPA | 5 days | Outcome Measure was pre-specified to assess ENG Implant plus oral UPA | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Ovulation With Implant-alone | ENG Implant Alone | 7 | Participants | ||
| Number of Participants With Ovulation With Implant-alone | ENG Implant Plus Oral UPA | 0 | Participants | ||
| Number of Participants With Ovulation With Implant and Same Day UPA | ENG Implant Alone | 0 | Participants | ||
| Number of Participants With Ovulation With Implant and Same Day UPA | ENG Implant Plus Oral UPA | 13 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | ENG Implant Alone | 20 | |
| Overall Study | STARTED | ENG Implant Plus Oral UPA | 20 | |
| Overall Study | COMPLETED | ENG Implant Alone | 20 | |
| Overall Study | COMPLETED | ENG Implant Plus Oral UPA | 19 | |
| Overall Study | NOT COMPLETED | ENG Implant Alone | 0 | |
| Overall Study | NOT COMPLETED | ENG Implant Plus Oral UPA | 1 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pain | Musculoskeletal and connective tissue disorders | ENG Implant Alone | 0 | 20 | 0 |
| other | Pain | Musculoskeletal and connective tissue disorders | ENG Implant Plus Oral UPA | 1 | 20 | 1 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | ENG Implant Alone | 0 | 20 |
| Total, all-cause mortality | ENG Implant Plus Oral UPA | 0 | 20 |
| Total, other adverse events | ENG Implant Alone | 0 | 20 |
| Total, other adverse events | ENG Implant Plus Oral UPA | 1 | 20 |
| Total, serious adverse events | ENG Implant Alone | 0 | 20 |
| Total, serious adverse events | ENG Implant Plus Oral UPA | 0 | 20 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| ENG Implant Alone vs ENG Implant Plus Oral UPA: deaths from any cause | Trial comparisons |
| ENG Implant Alone vs ENG Implant Plus Oral UPA: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04291001
GET https://conductscience.org/api/trials/v1/NCT04291001/registered